Oral Session 3   July 5    1:30pm - 5:20pm    8 speakers

Chairperson : Sang Taek Jung, Ph.D., Korea University,  Yong-Sung Kim, Ph.D., Ajou University

1:30pm - 1:55pm 

KBIO cell-based phage display panning system and its application to selecting mAbs against membrane protein targets

Yu Jung Kim, Ph.D., KBIOHEALTH

1:55pm - 2:20pm 

An efficient approach for membrane protein production as a drug target

Jung-Hyun Na, Ph.D., KBIOHEALTH

2:20pm - 2:45pm 

An innate immune checkpoint inhibitor for cancer immunotherapy

Sook Kyung Chang, Ph.D., ImmuneOncia Therapeutics Inc

2:45pm - 3:10pm 

Discovering novel immune checkpoints and its modulation for cancer therapy

Kyoung Wan Yoon, Ph.D., Genome & Company

3:10pm - 3:40pm 

Coffee Break & Poster Viewing 

3:40pm - 4:05pm 

Next Generation Bispecific Antibody Beyond Combination Therapy:

New Opportunity for Immuno-Oncology and CNS

Sang Hoon Lee, Ph.D, ABL Bio

4:05pm - 4:30pm

Single cell selections of recombinant antibodies binding to circulating tumor cells

Peter Kristensen, Ph.D., Arborg University

4:30pm - 4:55pm 

Novel long acting dual agonist for treatment of NASH and metabolic disease

Jong-Gyun Kim, Ph.D., Yuhan

4:55pm - 5:20pm

Site-selective Chemical Conjugation of Antibodies

Ju Hwan Kim, Ph.D., Abtis

© 2023 by The Antibody Society Korea. Proudly created with Wix.com